Research Options:
Week of Expected Pricing Withdrawn
Company Name HOVERINK BIOTECHNOLOGIES INC
Proposed Ticker N/A
CUSIP N/A
Business Description Pharmaceutical preparations for the treatment of gastrointestinal and oncological diseases and disorders. LADAVRU a non-opioid product.
Lead Underwriter N/A
Co-Managers Self-Underwritten
Initial Shares 2,000,000
Revised Initial Shares N/A
Initial Price $20.00-$20.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.